Back to Search
RAY SOMCIO, M.D.
M.D.
Pediatric Radiology Physician
NPI: 1245551126IndividualAccepts Medicare
Specialties, Licenses & Credentials
Student in an Organized Health Care Education/Training Program
Student in an Organized Health Care Education/Training Program
Code: 390200000X
BP10037232(TX)
Pediatric Radiology PhysicianPrimary
Radiology — Pediatric Radiology
Code: 2085P0229X
Q4292(TX)
CMS Specialties
PrimaryDIAGNOSTIC RADIOLOGY
Education
OTHER
Class of 2010
Research & Publications (18)
Therapeutic targeting of Id2 reduces growth of human colorectal carcinoma in the murine liver.
PMID 18806828·Oncogene·2008
7-preclinical
Effect of molecular therapeutics on liver regeneration in a murine model.
PMID 18398149·J Clin Oncol·2008
7-preclinical
Therapeutic targeting of neuropilin-2 on colorectal carcinoma cells implanted in the murine liver.
PMID 18182619·J Natl Cancer Inst·2008
7-preclinical
Regulation of cyclooxygenase-2 (COX-2) expression in human pancreatic carcinoma cells by the insulin-like growth factor-I receptor (IGF-IR) system.
PMID 17950526·Cancer Lett·2007
8-other
The development and characterization of a human midgut carcinoid cell line.
PMID 17699847·Clin Cancer Res·2007
7-preclinical
Targeting of insulin-like growth factor-I receptor with a monoclonal antibody inhibits growth of hepatic metastases from human colon carcinoma in mice.
PMID 17653802·Ann Surg Oncol·2007
7-preclinical
Overexpression of PDGF-BB decreases colorectal and pancreatic cancer growth by increasing tumor pericyte content.
PMID 17641778·J Clin Invest·2007
4-observational
The role of nitric oxide in mediating tumour blood flow.
PMID 16981826·Expert Opin Ther Targets·2006
6-review
Regulatory role of c-Met in insulin-like growth factor-I receptor-mediated migration and invasion of human pancreatic carcinoma cells.
PMID 16891453·Mol Cancer Ther·2006
8-other
Chronic oxaliplatin resistance induces epithelial-to-mesenchymal transition in colorectal cancer cell lines.
PMID 16857785·Clin Cancer Res·2006
8-other
Roles of nitric oxide synthase inhibition and vascular endothelial growth factor receptor-2 inhibition on vascular morphology and function in an in vivo model of pancreatic cancer.
PMID 16638876·Clin Cancer Res·2006
7-preclinical
Vascular endothelial growth factor receptor-1 activation mediates epithelial to mesenchymal transition in human pancreatic carcinoma cells.
PMID 16397214·Cancer Res·2006
8-other
Targeting of urokinase plasminogen activator receptor in human pancreatic carcinoma cells inhibits c-Met- and insulin-like growth factor-I receptor-mediated migration and invasion and orthotopic tumor growth in mice.
PMID 16140945·Cancer Res·2005
7-preclinical
Overexpression of neuropilin-1 promotes constitutive MAPK signalling and chemoresistance in pancreatic cancer cells.
PMID 15956974·Br J Cancer·2005
8-other
Vascular endothelial growth factor receptor-1 promotes migration and invasion in pancreatic carcinoma cell lines.
PMID 15952180·Cancer·2005
8-other
RON, a tyrosine kinase receptor involved in tumor progression and metastasis.
PMID 15827676·Ann Surg Oncol·2005
6-review
Improving delivery of antineoplastic agents with anti-vascular endothelial growth factor therapy.
PMID 15754332·Cancer·2005
6-review
Expression and function of vascular endothelial growth factor receptor-1 on human colorectal cancer cells.
PMID 15735759·Oncogene·2005
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 6701 FANNIN ST, SUITE 470
HOUSTON, TX 77030 - Phone
- (832) 824-7237
Quick Facts
- NPI
- 1245551126
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 1
- Years in Practice
- 16
- Publications
- 18
Are you this provider?
Claim Your Profile